Advertisement

Topics

Li Zhu from Legend Biotech (bottom right) says after their ASCO data in 2017 they were approached by eight large pharma companies. Ultimately chose $JNJ as the best partner because of their experience in hematology and the structure of the “50/50” dea

02:36 EDT 26 Mar 2019 | Brad Loncar

Li Zhu from Legend Biotech (bottom right) says after their ASCO data in 2017 they were approached by eight large pharma companies. Ultimately chose as the best partner because of their experience in hematology and the structure of the “50/50” deal they offered.

Original Article: Li Zhu from Legend Biotech (bottom right) says after their ASCO data in 2017 they were approached by eight large pharma companies. Ultimately chose $JNJ as the best partner because of their experience in hematology and the structure of the “50/50” dea

NEXT ARTICLE

More From BioPortfolio on "Li Zhu from Legend Biotech (bottom right) says after their ASCO data in 2017 they were approached by eight large pharma companies. Ultimately chose $JNJ as the best partner because of their experience in hematology and the structure of the “50/50” dea"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...